FTC Launches Probe into Surveillance Pricing Practices Targeting Eight Major Firms
The FTC launches an investigation into 'surveillance pricing,' targeting eight major firms to uncover how consumer data and AI influence individualized pricing.
The FTC launches an investigation into 'surveillance pricing,' targeting eight major firms to uncover how consumer data and AI influence individualized pricing.
Explore recent legal battles highlighting corporate and regulatory accountability, uncovering unethical practices and their consequences in various industries.
The pharmaceutical industry is currently facing significant legal challenges, with major players like AbbVie and Purdue Pharma at the center. Key cases include AbbVie's Supreme Court plea to protect its…
The FBI has intensified its scrutiny on the multifamily rental industry, particularly focusing on RealPage's controversial price-setting software. This federal crackdown, including a recent raid on Cortland's Atlanta headquarters, underscores…
Zillow Group Inc. and RealPage Inc. are facing significant antitrust legal challenges that could reshape the real estate technology landscape. Zillow's settlement involves MLS services blocking its ShowingTime tool, while…
Nvidia, the leading GPU maker, is under DOJ scrutiny for potential antitrust violations. As Nvidia's market dominance grows, concerns about monopolistic behavior arise. Learn more about the investigation and its…
The latest Hart-Scott-Rodino (HSR) Act transaction data for May 2024 reveals a surge in M&A activity, while economic indicators from the Bureau of Economic Analysis highlight a complex landscape. Discover…
Google's AI Overviews spark significant controversy by threatening journalism and reshaping digital advertising. Critics argue the feature siphons traffic from news publishers and spreads misinformation. The DOJ and antitrust experts…
Novartis faces significant legal battles over drug pricing and antitrust regulations, with several court cases highlighting industry-wide challenges. These include a $30 million settlement related to its hypertension drug, Exforge,…
The DOJ, in partnership with 29 states, sues Live Nation and Ticketmaster for antitrust violations, alleging monopolistic practices in live entertainment. The lawsuit aims to break the monopolistic hold, promoting…